• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

睾酮/雄烯二酮比值在评估卵巢雄激素过多女性中的应用

Testosterone/androstenedione ratio in the evaluation of women with ovarian androgen excess.

作者信息

Wiebe R H, Morris C V

出版信息

Obstet Gynecol. 1983 Mar;61(3):279-84.

PMID:6296743
Abstract

A plasma testosterone/androstenedione (T/A) ratio was calculated in 15 women with possible ovarian neoplasms and androgen excess and whose mean plasma concentration of testosterone approached or was greater than a twofold elevation. The T/A ratio approached unity in eight of nine patients with polycystic ovarian disease, whereas all patients with hyperthecosis and two of three patients with androgen-secreting tumors had a testosterone/androstenedione ratio above 1.5. In 13 of 16 patients with androgen-secreting tumors of the ovary reported in the literature, the testosterone/androstenedione ratio was above 1.5. An elevated testosterone/androstenedione ratio should raise the suspicion of either an ovarian androgen-secreting tumor or hyperthecosis.

摘要

对15名可能患有卵巢肿瘤且雄激素水平过高、血浆睾酮平均浓度接近或高于两倍升高水平的女性,计算了血浆睾酮/雄烯二酮(T/A)比值。在9例多囊卵巢疾病患者中,有8例的T/A比值接近1,而所有卵泡膜增生患者以及3例雄激素分泌性肿瘤患者中的2例,其睾酮/雄烯二酮比值高于1.5。在文献报道的16例卵巢雄激素分泌性肿瘤患者中,有13例的睾酮/雄烯二酮比值高于1.5。睾酮/雄烯二酮比值升高应引起对卵巢雄激素分泌性肿瘤或卵泡膜增生的怀疑。

相似文献

1
Testosterone/androstenedione ratio in the evaluation of women with ovarian androgen excess.睾酮/雄烯二酮比值在评估卵巢雄激素过多女性中的应用
Obstet Gynecol. 1983 Mar;61(3):279-84.
2
Androgen and estrogen formation in women with ovarian hyperthecosis.卵巢泡膜细胞增生症女性体内雄激素和雌激素的生成
Obstet Gynecol. 1978 Jan;51(1):1-9.
3
[Endocrine profile and electron microscopic study of ovarian androblastoma].[卵巢含雄激素细胞瘤的内分泌特征及电镜研究]
Nihon Sanka Fujinka Gakkai Zasshi. 1984 Aug;36(8):1155-62.
4
Peripheral and ovarian venous concentrations of various steroid hormones in virilizing ovarian tumors.男性化卵巢肿瘤中各种甾体激素的外周血和卵巢静脉血浓度
Obstet Gynecol. 1979 Jan;53(1):36-43.
5
Malignant ovarian Sertoli-Leydig cell tumor localized with selective ovarian vein sampling.卵巢恶性 Sertoli-Leydig 细胞肿瘤经选择性卵巢静脉采样定位。
J Minim Invasive Gynecol. 2012 Nov-Dec;19(6):789-93. doi: 10.1016/j.jmig.2012.08.006.
6
Arrhenoblastomas and associated ovarian pathology.睾丸母细胞瘤及相关卵巢病理
Obstet Gynecol. 1974 Apr;43(4):539-43.
7
Sertoli-Leydig cell tumor of the ovary, with an associated mucinous cystadenoma. An ultrastructural and endocrine study.
Lab Invest. 1974 Dec;31(6):648-57.
8
The levels of androgen in serum in female acne patients.女性痤疮患者血清中的雄激素水平。
Endocrinol Exp. 1985 Mar;19(1):17-23.
9
Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours.GnRH 激动剂对卵巢卵泡膜细胞增生症和男性化肿瘤的雄激素抑制作用。
Clin Endocrinol (Oxf). 1994 Nov;41(5):571-6. doi: 10.1111/j.1365-2265.1994.tb01820.x.
10
[Androgenic alopecia revealing an androgen secreting ovarian tumor].雄激素性脱发揭示了一种分泌雄激素的卵巢肿瘤
Ann Dermatol Venereol. 2001 Nov;128(11):1241-4.

引用本文的文献

1
The intraovarian actions of estrogen receptor-alpha are necessary to repress the formation of morphological and functional Leydig-like cells in the female gonad.雌激素受体α的卵巢内作用对于抑制雌性性腺中形态和功能类似睾丸间质细胞的细胞形成是必要的。
Endocrinology. 2006 Aug;147(8):3666-78. doi: 10.1210/en.2006-0276. Epub 2006 Apr 20.